Lipidic prodrug nanosponges deliver proteins for combination therapy of candida-biofilm infections
Bibliographic record
Abstract
No abstract is available for this record. The assistant can identify its topic from the title, but cannot infer the study’s results.
Source: Not provided · Quality: missing
Research context
OpenAlex topics: Advanced Drug Delivery Systems · Bacterial biofilms and quorum sensing · Oral microbiology and periodontitis research
SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.
References (65)
Show source-provided references
1. Self-assembled lipid–prodrug nanoparticles10.1038/s44222-023-00082-0 ↗
2. Engineering of small-molecule lipidic prodrugs as novel nanomedicines for enhanced drug delivery10.1186/s12951-022-01257-4 ↗
3. Polyzwitterionic micelles with antimicrobial-conjugation for eradication of drug-resistant bacterial biofilms10.1016/j.colsurfb.2023.113542 ↗
4. Prodrugs: design and clinical applications10.1038/nrd2468 ↗
5. One-component nanomedicine10.1016/j.jconrel.2015.09.056 ↗
6. Nanotechnology-based antimicrobials and delivery systems for biofilm-infection control10.1039/C7CS00807D ↗
7. Nanomaterial-based therapeutics for antibiotic-resistant bacterial infections10.1038/s41579-020-0420-1 ↗
8. Controlled drug delivery systems in eradicating bacterial biofilm-associated infections10.1016/j.jconrel.2020.10.038 ↗
9. Antimicrobial hybrid amphiphile via dynamic covalent bonds enables bacterial biofilm dispersal and bacteria eradication10.1002/adfm.202214299 ↗
10. One-component lipidic bicontinuous nanospheres as a smart drug loading platform to eradicate Candida biofilms in oral and vaginal infection10.1016/j.nantod.2023.102123 ↗
11. Lipid prodrug nanoassemblies via dynamic covalent boronates10.1021/acsnano.2c12233 ↗
12. Emerging strategies in stimuli-responsive prodrug nanosystems for cancer therapy10.1021/acsnano.2c05379 ↗
13. Theranostic prodrug vesicles for reactive oxygen species-triggered ultrafast drug release and local-regional therapy of metastatic triple-negative breast cancer
14. Targeting fatty-acid amide hydrolase with prodrugs for CNS-selective therapy10.1021/acschemneuro.7b00239 ↗
15. Two-tailed dynamic covalent amphiphile combats bacterial biofilms10.1002/adma.202301623 ↗
16. Triclosan-conjugated, lipase-responsive polymeric micelles for eradication of staphylococcal biofilms10.1007/s10118-024-3094-8 ↗
17. Emerging insights on drug delivery by fatty acid mediated synthesis of lipophilic prodrugs as novel nanomedicines10.1016/j.jconrel.2020.07.012 ↗
18. Drug-sponge lipid nanocarrier for in situ cargo loading and release using dynamic covalent chemistry10.1002/anie.202014259 ↗
19. Lipids and lipid-based formulations: optimizing the oral delivery of lipophilic drugs10.1038/nrd2197 ↗
20. Rational design of nanocarriers for intracellular protein delivery10.1002/adma.201902791 ↗
21. Protein therapeutics: a summary and pharmacological classification10.1038/nrd2399 ↗
22. Oral delivery of therapeutic peptides and proteins: technology landscape of lipid-based nanocarriers10.1016/j.addr.2021.114097 ↗
23. Tailoring nanocarriers for intracellular protein delivery10.1039/c0cs00227e ↗
24. Neurotransmitter-derived lipidoids (NT-lipidoids) for enhanced brain delivery through intravenous injection10.1126/sciadv.abb4429 ↗
25. Nanotechnology for protein delivery: Overview and perspectives10.1016/j.jconrel.2015.10.012 ↗
26. Molecular insights on confined water in the nanochannels of self-assembled ionic liquid crystal10.1126/sciadv.abf0669 ↗
27. Light-responsive molecular release from cubosomes using swell-squeeze lattice control10.1021/jacs.2c08583 ↗
28. Molecular interaction of proteins and peptides with nanoparticles10.1021/nn300415x ↗
29. Stimuli-responsive nanomaterials for therapeutic protein delivery10.1016/j.jconrel.2014.08.015 ↗
30. A nanotrap improves survival in severe sepsis by attenuating hyperinflammation10.1038/s41467-020-17153-0 ↗
31. A boronic acid–rich dendrimer with robust and unprecedented efficiency for cytosolic protein delivery and CRISPR-Cas9 gene editing10.1126/sciadv.aaw8922 ↗
32. DNase increases the efficacy of antimicrobial photodynamic therapy on Candida albicans biofilms10.1016/j.pdpdt.2019.05.038 ↗
33. Supramolecular photothermal cascade nano-reactor enables photothermal effect, cascade reaction, and in situ hydrogelation for biofilm-associated tooth-extraction wound healing
34. Metal-phenolic network with Pd nanoparticle nodes synergizes oxidase-like and photothermal properties to eradicate oral polymicrobial biofilm-associated infections
35. Tolerance and resistance of microbial biofilms10.1038/s41579-022-00682-4 ↗
36. Targeting microbial biofilms: current and prospective therapeutic strategies10.1038/nrmicro.2017.99 ↗
37. Ion formation in MALDI: the cluster ionization mechanism10.1021/cr010376a ↗
38. Isolated Entamoeba histolytica actin does not inhibit DNAse-I activity10.1016/0006-291X(82)91953-2 ↗
39. Redesign of protein nanocages: the way from 0D, 1D, 2D to 3D assembly10.1039/D0CS01349H ↗
40. Protective liquid crystal nanoparticles for targeted delivery of PslG: a biofilm dispersing enzyme10.1021/acsinfecdis.1c00014 ↗
41. Triggered degradable colloidal particles with ordered inverse bicontinuous cubic and hexagonal mesophases10.1021/acsnano.0c09166 ↗
42. Cubosomes: the next generation of smart lipid nanoparticles?10.1002/anie.201804067 ↗
43. Microenvironment-adaptive metallo-polymeric nanodecoys via subcomponent coordination for bacterial biofilm eradication and immunomodulation
44. A guanosine-quadruplex hydrogel as cascade reaction container consuming endogenous glucose for infected wound treatment—a study in diabetic mice
45. Multifactorial mechanisms of tolerance to ketoconazole in Candida albicans10.1128/Spectrum.00321-21 ↗
46. Fighting antibiotic-resistant bacteria: promising strategies orchestrated by molecularly imprinted polymers10.1002/anie.202106493 ↗
47. Biofilm mechanics: implications in infection and survival10.1016/j.bioflm.2019.100017 ↗
48. Nutrient acquisition by pathogenic fungi: nutrient availability, pathway regulation, and differences in substrate utilization10.1016/j.ijmm.2011.04.007 ↗
49. Arginine metabolism governs microcycle conidiation by changing nitric oxide content in Metarhizium acridum10.1007/s00253-022-12355-6 ↗
50. Mouse model of oropharyngeal candidiasis10.1038/nprot.2012.011 ↗
51. Dynamic covalent nano-networks comprising antibiotics and polyphenols orchestrate bacterial drug resistance reversal and inflammation alleviation
52. Engineered Bdellovibrio bacteriovorus: a countermeasure for biofilm-induced periodontitis10.1016/j.mattod.2022.01.013 ↗
53. Hierarchical Superstructure of Plant Polyphenol and Arginine Surfactant for Long-lasting and Target-selective Antimicrobial Application10.1002/adma.202210936 ↗
54. High drug-loading nanomedicines: progress, current status, and prospects10.2147/IJN.S132780 ↗
55. Nanomedicine from amphiphilized prodrugs: concept and clinical translation10.1016/j.addr.2021.114027 ↗
56. Engineering the drug carrier biointerface to overcome biological barriers to drug delivery10.1016/j.addr.2020.06.007 ↗
57. Breaking isolation to form new networks: pH-triggered changes in connectivity inside lipid nanoparticles10.1021/jacs.1c06244 ↗
58. Polymers for cytosolic protein delivery10.1016/j.biomaterials.2019.119358 ↗
59. Protein delivery into cells using inorganic nanoparticle-protein supramolecular assemblies10.1039/C8CS00008E ↗
60. Surviving as a community: antibiotic tolerance and persistence in bacterial biofilms10.1016/j.chom.2019.06.002 ↗
61. Nanorobots to treat candida albicans infection10.34133/research.0455 ↗
62. A probiotic nanozyme hydrogel regulates vaginal microenvironment for Candida vaginitis therapy
63. Characterization of human DNase I family endonucleases and activation of DNase γ during apoptosis10.1021/bi001041a ↗
64. A functional DNase I coating to prevent adhesion of bacteria and the formation of biofilm10.1002/adfm.201202927 ↗
65. Inflammation and microbiota regulation potentiate pneumonia therapy by biomimetic bacteria and macrophage membrane nanosystem10.34133/research.0096 ↗